Changes in the Survival of Patients with Breast Cancer: Poland, 2000-2019

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 2022 Dec 12

PMID 36509986

Authors

Florentino Luciano Caetano Dos Santos

Irmina Maria Michalek

Urszula Wojciechowska

Joanna Didkowska

Affiliations

Soon will be listed here.

Abstract

Purpose: The main aim of this study was to estimate breast cancer survival in Poland over the period from 2000 to 2019 in both sexes.

Methods: Data were obtained from the Polish National Cancer Registry. The presented metrics included age-standardized 5- and 10-year net survival (NS), median survival times, years of life lost (YLLs), and standardized mortality ratios (SMRs).

Results: Between 2000 and 2019, 315,278 patients (2353 men and 312,925 women; male-to-female ratio 1/100) were diagnosed with breast cancer in Poland. In this period, 721,987 YLLs were linked to breast cancer. Women presented a higher 5- and 10-year age-standardized NS than men (5-year NS: 77.33% for women and 65.47% for men, P < 0.001, common language effect size (CL) 1.00; 10-year NS: 68.75% for women and 49.50% for men, P < 0.001, CL 1.00). Between the earliest and latest studied period, namely 2000-2004 and 2015-2019, there was a statistically significant increase only in female survival (+ 7.32 pp, P < 0.001, CL 1.00). SMRs were significantly higher for women than for men (3.35 vs. 2.89, respectively).

Conclusion: Over the last two decades, breast cancer survival in Poland has improved significantly. Nonetheless, special attention should be given to the disparities between sexes and the gap in overall improvement of survival rates compared with other European countries.

Citing Articles

Five-year overall and specific survival of breast cancer in great Cuiaba (MT), Brazil.

Oliveira J, Galvao N, Andrade A, Silva A Rev Bras Epidemiol. 2025; 28:e250010.

PMID: 40053007 PMC: 11884821. DOI: 10.1590/1980-549720250010.

Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data.

Tang D, Ye Z, Liu W, Wu J, Tan J, Zhang Y Breast. 2024; 79:103862.

PMID: 39701013 PMC: 11722932. DOI: 10.1016/j.breast.2024.103862.

Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis.

Dai Y, Lan J, Li S, Xu G Breast Care (Basel). 2024; 19(6):316-328.

PMID: 39691361 PMC: 11649298. DOI: 10.1159/000541421.

Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival.

Varzaru V, Anastasiu-Popov D, Eftenoiu A, Popescu R, Vlad D, Vlad C Cancers (Basel). 2024; 16(17).

PMID: 39272907 PMC: 11394319. DOI: 10.3390/cancers16173049.

Long-Term Outcomes of Breast Cancer Patients Receiving Levobupivacaine Wound Infiltration or Diclofenac for Postoperative Pain Relief.

Glavas Tahtler J, Djapic D, Neferanovic M, Miletic J, Milosevic M, Kralik K Pharmaceutics. 2023; 15(9).

PMID: 37765154 PMC: 10534840. DOI: 10.3390/pharmaceutics15092183.

References

Rawla P, Sunkara T, Gaduputi V . Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019; 10(1):10-27. PMC: 6396775. DOI: 10.14740/wjon1166. View

Mattiuzzi C, Lippi G . Current Cancer Epidemiology. J Epidemiol Glob Health. 2019; 9(4):217-222. PMC: 7310786. DOI: 10.2991/jegh.k.191008.001. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Jung K, Park S, Shin A, Oh C, Kong H, Jun J . Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009. PLoS One. 2013; 7(12):e52457. PMC: 3530449. DOI: 10.1371/journal.pone.0052457. View

Fidler M, Soerjomataram I, Bray F . A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016; 139(11):2436-46. DOI: 10.1002/ijc.30382. View

DiPippo A, Patel N, Barnett C . Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future. Pharmacotherapy. 2016; 36(6):652-67. DOI: 10.1002/phar.1756. View

Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J . Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol. 2019; 12(1):96. PMC: 6740016. DOI: 10.1186/s13045-019-0783-9. View

Pohar M, Stare J . Relative survival analysis in R. Comput Methods Programs Biomed. 2006; 81(3):272-8. DOI: 10.1016/j.cmpb.2006.01.004. View

Cutler S, Ederer F . Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958; 8(6):699-712. DOI: 10.1016/0021-9681(58)90126-7. View

10.

Fox S, Speirs V, Shaaban A . Male breast cancer: an update. Virchows Arch. 2021; 480(1):85-93. DOI: 10.1007/s00428-021-03190-7. View

11.

Uhlenhopp D, Then E, Sunkara T, Gaduputi V . Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020; 13(6):1010-1021. DOI: 10.1007/s12328-020-01237-x. View

12.

Grinda T, Antoine A, Jacot W, Blaye C, Cottu P, Dieras V . Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. 2021; 6(3):100114. PMC: 8095121. DOI: 10.1016/j.esmoop.2021.100114. View

13.

Sant M, Chirlaque Lopez M, Agresti R, Sanchez Perez M, Holleczek B, Bielska-Lasota M . Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. Eur J Cancer. 2015; 51(15):2191-2205. DOI: 10.1016/j.ejca.2015.07.022. View

14.

Brydges C . Effect Size Guidelines, Sample Size Calculations, and Statistical Power in Gerontology. Innov Aging. 2019; 3(4):igz036. PMC: 6736231. DOI: 10.1093/geroni/igz036. View

15.

Chesebro A, Rives A, Shaffer K . Male Breast Disease: What the Radiologist Needs to Know. Curr Probl Diagn Radiol. 2018; 48(5):482-493. DOI: 10.1067/j.cpradiol.2018.07.003. View

16.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

17.

Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View

18.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

19.

Lin Y, Yang Z, Li J, Sun Y, Zhang X, Qu Z . Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study. BMC Genomics. 2022; 23(1):213. PMC: 8925075. DOI: 10.1186/s12864-022-08442-7. View

20.

Ferlay J, Colombet M, Soerjomataram I, Parkin D, Pineros M, Znaor A . Cancer statistics for the year 2020: An overview. Int J Cancer. 2021; . DOI: 10.1002/ijc.33588. View